Charles River Labs' Shanghai Facility Wins Animal Care Accreditations

Oct. 8.09 | About: Charles River (CRL)

Charles River Laboratories, Inc. (NYSE: CRL) reported that its year-old Shanghai CRO facility has received three accreditations from organizations protecting the care of laboratory animals: the Association for Assessment and Accreditation of Laboratory Animal Care ((AAALAC)), the Canadian Council on Animal Care (CCAC) and the Shanghai Laboratory Animal Commission (SLAC). The CRO is a joint venture between Charles River and Shanghai BioExplorer, with Charles River being the majority partner.

Charles River opened its 60,000 square foot Shanghai preclinical facility last October. Charles River has said the facility will provide China-based preclinical CRO services to international biopharmas that are already Charles River clients, though it also will seek business from domestic biopharmas.

Dr. Kewin Jin is the General Manager of Charles River Shanghai. Jin co-founded Shanghai BioExplorer in 2002. He was trained in medicine at the Shanghai Second Medical University, received his PhD in molecular biology at Rockefeller University and studied finance at Columbia University.

“These three accreditations are a milestone in Charles River’s strategy to create a Center of Excellence in China,” said James C. Foster, President, Chairman and Chief Executive Officer of Charles River in a statement. “As the leading international CRO with GLP capabilities in China, we are replicating the Company’s high standards of research, safety, humane care and laboratory best practices that globally distinguish Charles River.”

Disclosure: none.